BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37487524)

  • 1. Management of Pulmonary Hypertension Associated with Chronic Lung Disease.
    Blanco I; Hernández-González F; García A; Torres-Castro R; Barberà JA
    Semin Respir Crit Care Med; 2023 Dec; 44(6):826-839. PubMed ID: 37487524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.
    Barberà JA; Blanco I
    Curr Hypertens Rep; 2015 Aug; 17(8):62. PubMed ID: 26115628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA; Blanco I
    Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in chronic obstructive and interstitial lung diseases.
    Andersen CU; Mellemkjær S; Nielsen-Kudsk JE; Bendstrup E; Hilberg O; Simonsen U
    Int J Cardiol; 2013 Oct; 168(3):1795-804. PubMed ID: 23849967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary hypertension associated with lung disease].
    Halank M; Zeder KE; Sommer N; Ulrich S; Held M; Köhler T; Foris V; Heberling M; Neurohr C; Ronczka J; Holt S; Skowasch D; Kneidinger N; Behr J
    Pneumologie; 2023 Nov; 77(11):916-925. PubMed ID: 37963481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    King CS; Shlobin OA
    Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in the course of diffuse parenchymal lung diseases - state of art and future considerations.
    Szturmowicz M; Kacprzak A; Błasińska-Przerwa K; Kuś J
    Pneumonol Alergol Pol; 2015; 83(4):312-23. PubMed ID: 26166793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interstitial lung diseases and pulmonary hypertension].
    Hauber HP
    Internist (Berl); 2009 Sep; 50(9):1072, 1074-6, 1078-9. PubMed ID: 19575171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
    Rahaghi FF; Kolaitis NA; Adegunsoye A; de Andrade JA; Flaherty KR; Lancaster LH; Lee JS; Levine DJ; Preston IR; Safdar Z; Saggar R; Sahay S; Scholand MB; Shlobin OA; Zisman DA; Nathan SD
    Chest; 2022 Jul; 162(1):145-155. PubMed ID: 35176276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E; Chaouat A; Kessler R
    Pneumonol Alergol Pol; 2013; 81(4):390-8. PubMed ID: 23744170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension associated with lung disease].
    Richter MJ; Tello K
    Herz; 2023 Aug; 48(4):274-279. PubMed ID: 37106074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial lung disease-associated pulmonary hypertension - what the future holds.
    Cottin V; Diesler R; Turquier S; Valenzuela C
    Curr Opin Pulm Med; 2023 Sep; 29(5):406-415. PubMed ID: 37417835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in group 3 pulmonary hypertension.
    Harder EM; Waxman AB
    Curr Opin Pulm Med; 2020 Sep; 26(5):391-396. PubMed ID: 32657833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE DIFFICULTIES IN THE DIAGNOSIS OF PULMONARY HYPERTENSION ASSOCIATED WITH CHRONIC LUNG DISEASE.
    Łukasik S; Łukasik D; Tomaszewski M; Topyła W; Wojtowska A; Szopa A; Wysokiński A
    Wiad Lek; 2020; 73(9 cz. 1):1853-1860. PubMed ID: 33099529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in interstitial lung disease.
    Behr J; Ryu JH
    Eur Respir J; 2008 Jun; 31(6):1357-67. PubMed ID: 18515559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.